- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT04015726
Secular Trends in the Prevalence of Cardiometabolic Risk Factors Among Teenage School Children in Urban South India
Aperçu de l'étude
Statut
Les conditions
Description détaillée
This programme will be conducted after obtaining prior permission from the Directorate of School Education, Government of Tamil Nadu and school authorities. This study will be conducted in 22 schools in Chennai involving 2815 students of age group 12 to 18 years. Initially the study and its procedure will be explained to the principal and the teachers of the school. Request the school authority to fix a date for each standard/grade to explain about the informed consent / assent form and the study process to the students. The students will be asked to give the informed consent/assent form to their parents and asked to get their signature in the specified place. Instruction will be given to the students that their parents can call the Investigator if they have any doubts in the informed consent/assent form. After giving ample time for the informed consent process the students will be asked to give the informed consent when the research team goes to the school. The informed consent should be countersigned by the teachers to confirm the authenticity of the parent's signature. The research team gets the signature from the student in the assent form. A date is finalized with the school authority for the screening. The students are advised to come in fasting for the test. On the day of screening the student will be given a screening number. Necessary details such as personal and family information, anthropometry (height, weight, waist circumference, body fat) and blood pressure will be measured. Medical history, diet, physical activity, and sleep habits and questionnaire on awareness on diabetes will be recorded. Laboratory investigations such as fasting blood glucose, plasma insulin and lipid profile (Total Cholesterol, Triglyceride, Low-Density Lipoprotein (LDL), Very Low-Density Lipoprotein (VLDL) and High-Density Lipoprotein (HDL)) will be measured.
After the assessment, the students will be given refreshments and a few minutes of rest. The samples will be sent to the central laboratory for analyses. The reports will be distributed to the students within a week's time. Parents will be personally contacted by the research team if there is any concern in the lab report which requires medical attention.
Type d'étude
Inscription (Anticipé)
Contacts et emplacements
Lieux d'étude
-
-
Tamil Nadu
-
Chennai, Tamil Nadu, Inde, 600008
- Recrutement
- India Diabetes Research Foundation
-
Contact:
- Ambady Ramachandran, MD, PhD, DSc
-
Chercheur principal:
- Ambady Ramachandran, MD, PhD, DSc
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
Méthode d'échantillonnage
Population étudiée
La description
Inclusion Criteria:
- Children both boys and girls between 12 - 18yrs age group
- Parents and child willing to give informed consent
- Children must be available for and willing to attend all evaluation visits
- Willingness to follow the protocol requirements as evidenced by written informed consent
Exclusion Criteria:
- Children below the age of 12 years and above the age of 18 years
- Parents or Child who is not willing to participate in the study
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Modèles d'observation: Autre
- Perspectives temporelles: Transversale
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Prevalence of central adiposity
Délai: baseline
|
Among adolescent children in 2019 in comparison with 2006 data
|
baseline
|
|
Prevalence of dysglycemia
Délai: Baseline
|
Among adolescent children in 2019 in comparison with 2006 data
|
Baseline
|
|
Prevalence of dyslipidemia
Délai: Baseline
|
Among adolescent children in 2019 in comparison with 2006 data
|
Baseline
|
|
Prevalence of hypertension
Délai: Baseline
|
Among adolescent children in 2019 in comparison with 2006 data
|
Baseline
|
|
Prevalence of insulin resistance
Délai: Baseline
|
Among adolescent children in 2019 in comparison with 2006 data
|
Baseline
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Prevalence of overweight
Délai: Baseline
|
Among adolescent children in 2019 in comparison with 2006 data
|
Baseline
|
|
Prevalence of obesity
Délai: Baseline
|
Among adolescent children in 2019 in comparison with 2006 data
|
Baseline
|
|
Changes in diet habit
Délai: Baseline
|
Among adolescent children in 2019 in comparison with 2006 data
|
Baseline
|
|
Changes in duration of physical activity
Délai: Baseline
|
Among adolescent children in 2019 in comparison with 2006 data
|
Baseline
|
Collaborateurs et enquêteurs
Les enquêteurs
- Chercheur principal: Ambady Ramachandran, MD, PhD, DSc, Senior Research Officer
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Anticipé)
Achèvement de l'étude (Anticipé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- IDRFARH012
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .